1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Gluten Sensitivity: new trials by email Literature Review of Gluten Sensitivity trials Research Report on Gluten Sensitivity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD) Nexvax2, Placebo - Celiac Disease, Celiac | Phase 2 | Unknown | ImmusanT, Inc. | 146 | 2018-08-06 | 2019-03-19 |
Autoimmune Diseases (1) · Celiac Disease (1) · Digestive System Diseases (1) · Gastrointestinal Diseases (1) · Intestinal Diseases (1) · Malabsorption Syndromes (1)
Immune System Diseases (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1)
Nexvax2 (1)
ImmusanT, Inc. (1)
Australia (1) · New Zealand (1) · United States (1)
Robert Anderson, PhD, FRACP (1)